Historical record - last NADAC effective date: 8/23/2023
Product Information
PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0808 per EA under NDC 43547042650. Its NADAC has been published 218 times since Jun 26, 2019.
FDA first approved this application on Apr 17, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Pioglitazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547042650
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/23/2023
Active Ingredients
PIOGLITAZONEApproval Type
Generic (ANDA)
FDA Application
ANDA207806FDA Approved
4/17/2018
TE Code
AB
On Market Since
5/20/2018
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 218 times since Jun 26, 2019, and over the history we have for it it has declined 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0808 per EA |
|---|---|
| All-time high | $0.1175 (May 13, 2020) |
| All-time low | $0.0780 (Apr 19, 2023) |
| Median price | $0.1021 |
| Average price | $0.0984 |
| Largest weekly change | +13.8% (Apr 22, 2020) |
| Weeks tracked | 218 |
| Tracking since | Jun 26, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-23.4%
All
-13.4%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pioglitazone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0808 per EA (NDC 43547042650), effective Aug 23, 2023.
How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 13.4%. It has been tracked across 218 weekly CMS publications since Jun 26, 2019.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?
Since Jun 26, 2019, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0780 (Apr 19, 2023) to a high of $0.1175 (May 13, 2020), with a median of $0.1021 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIOGLITAZONE HCL 15 MG TABLET, is $0.0675 per EA — about 16% below PIOGLITAZONE HCL 15 MG TABLET.
Who manufactures PIOGLITAZONE HCL 15 MG TABLET?
PIOGLITAZONE HCL 15 MG TABLET (NDC 43547042650) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.